* patients with severity criteria defined in the coronavirus disease epidemiological and laboratory surveillance guide (version 3/11/2020) * pregnant or breastfeeding women * women of childbearing age and without commitment to use contraceptive methods during the study time. * inability to complete the study * current treatment with drugs known to interact with ivermectin * known intolerance to ivermectin, its derivate or any of its excipients. * patients with known child-pugh c liver disease * patients with prior ivermectin consumption in the 10 days prior to study entry.

* patients with severity criteria defined in the coronavirus disease epidemiological and laboratory surveillance guide (version 3/11/2020) * pregnant or breastfeeding women * women of childbearing age and without commitment to use contraceptive methods during the study time. * inability to complete the study * current treatment with drugs known to interact with ivermectin * known intolerance to ivermectin, its derivate or any of its excipients. * patients with known child-pugh c liver disease * patients with prior ivermectin consumption in the 10 days prior to study entry.

- patients with severity criteria defined in the coronavirus disease epidemiological and laboratory surveillance guide (version 3/11/2020) - pregnant or breastfeeding women - women of childbearing age and without commitment to use contraceptive methods during the study time. - inability to complete the study - current treatment with drugs known to interact with ivermectin - known intolerance to ivermectin, its derivate or any of its excipients. - patients with known child-pugh c liver disease - patients with prior ivermectin consumption in the 10 days prior to study entry.

- patients with severity criteria defined in the coronavirus disease epidemiological and laboratory surveillance guide (version 3/11/2020) - pregnant or breastfeeding women - women of childbearing age and without commitment to use contraceptive methods during the study time. - inability to complete the study - current treatment with drugs known to interact with ivermectin - known intolerance to ivermectin, its derivate or any of its excipients. - patients with known child-pugh c liver disease - patients with prior ivermectin consumption in the 10 days prior to study entry.